三星1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张

路透中文06-25 21:13

BUZZ-<a href="https://laohu8.com/S/SMSN.UK">三星</a>1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张

6月25日 - ** Grail公司（GRAL.O）股价在盘前交易中上涨6.2%，至68.58美元

** 这家癌症检测制造商表示，已通过向三星旗下公司出售股权筹集了1.1亿美元，用于支持业务增长和全球扩张

** 并补充称，此次投资的定价为每股70.05美元

** 指出与三星C&T的合作旨在将Galleri癌症筛查检测引入韩国，并可能推广至日本和新加坡

** 公司表示，Galleri可筛查50多种癌症，其中包括一些常规检测无法覆盖的癌症

** 检测工作初期将在北卡罗来纳州的实验室进行——GRAL

** GRAIL补充称，该检测尚未获得美国FDA批准，且无法检测所有癌症

** 截至上一交易日收盘，该股年内累计跌幅约为25%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2646783803?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-06-25 21:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646783803","market":"us","top_or_hot":-1,"title":"三星1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张</title></head><body><p><span>6月25日</span><span> - </span>** Grail公司（<span>GRAL.O</span>）股价在盘前交易中上涨6.2%，至68.58美元</p><p>** 这家癌症检测制造商表示，已通过向三星旗下公司出售股权筹集了1.1亿美元，用于支持业务增长和全球扩张</p><p>** 并补充称，此次投资的定价为每股70.05美元</p><p>** 指出与三星C&amp;T的合作旨在将Galleri癌症筛查检测引入韩国，并可能推广至日本和新加坡</p><p>** 公司表示，Galleri可筛查50多种癌症，其中包括一些常规检测无法覆盖的癌症</p><p>** 检测工作初期将在北卡罗来纳州的实验室进行——GRAL</p><p>** GRAIL补充称，该检测尚未获得美国FDA批准，且无法检测所有癌症</p><p>** 截至上一交易日收盘，该股年内累计跌幅约为25% </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>三星1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n三星1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-06-25 21:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张</title></head><body><p><span>6月25日</span><span> - </span>** Grail公司（<span>GRAL.O</span>）股价在盘前交易中上涨6.2%，至68.58美元</p><p>** 这家癌症检测制造商表示，已通过向三星旗下公司出售股权筹集了1.1亿美元，用于支持业务增长和全球扩张</p><p>** 并补充称，此次投资的定价为每股70.05美元</p><p>** 指出与三星C&amp;T的合作旨在将Galleri癌症筛查检测引入韩国，并可能推广至日本和新加坡</p><p>** 公司表示，Galleri可筛查50多种癌症，其中包括一些常规检测无法覆盖的癌症</p><p>** 检测工作初期将在北卡罗来纳州的实验室进行——GRAL</p><p>** GRAIL补充称，该检测尚未获得美国FDA批准，且无法检测所有癌症</p><p>** 截至上一交易日收盘，该股年内累计跌幅约为25% </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GRAL","symbol_name":"GRAIL, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4T42X1B5:1","article_id":"2646783803","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2646783803","pubTimestamp":1782393196,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-三星1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张6月25日-** Grail公司（GRAL.O）股价在盘前交易中上涨6.2%，至68.58美元** 这家癌症检测制造商表示，已通过向三星旗下公司出售股权筹集了1.1亿美元，用于支持业务增长和全球扩张** 并补充称，此次投资的定价为每股70.05美元** 指出与三星C&T的合作旨在将Galleri癌症筛查检测引入韩国，并可能推广至","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"GRAL":"GRAIL, Inc.","BK4139":"生物科技"},"translate_title":"Grail stock rises to boost cancer testing expansion as Samsung injects $110 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRAL":0.9},"content_text":"BUZZ-三星1.1亿美元注资，Grail股价上涨助推癌症检测业务扩张6月25日 - ** Grail公司（GRAL.O）股价在盘前交易中上涨6.2%，至68.58美元** 这家癌症检测制造商表示，已通过向三星旗下公司出售股权筹集了1.1亿美元，用于支持业务增长和全球扩张** 并补充称，此次投资的定价为每股70.05美元** 指出与三星C&T的合作旨在将Galleri癌症筛查检测引入韩国，并可能推广至日本和新加坡** 公司表示，Galleri可筛查50多种癌症，其中包括一些常规检测无法覆盖的癌症** 检测工作初期将在北卡罗来纳州的实验室进行——GRAL** GRAIL补充称，该检测尚未获得美国FDA批准，且无法检测所有癌症** 截至上一交易日收盘，该股年内累计跌幅约为25%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646783803","isCrawlerRequest":true}